Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2.

Kitagawa M, Higashi H, Jung HK, Suzuki-Takahashi I, Ikeda M, Tamai K, Kato J, Segawa K, Yoshida E, Nishimura S, Taya Y.

EMBO J. 1996 Dec 16;15(24):7060-9.

2.

Induction of S phase by G1 regulatory factors.

Kato J.

Front Biosci. 1999 Dec 1;4:D787-92. Review.

3.

[The characterization of human cdc2 kinase and CDK2].

Yasuda H, Kamijo M, Ohba Y.

Yakugaku Zasshi. 1993 Dec;113(12):829-46. Review. Japanese.

PMID:
8301538
4.

Regulation of the retinoblastoma tumor suppressor protein by cyclin/cdks.

Adams PD.

Biochim Biophys Acta. 2001 Mar 21;1471(3):M123-33. Review.

PMID:
11250068
5.

Regulatory interactions among E2Fs and cell cycle control proteins.

Cobrinik D.

Curr Top Microbiol Immunol. 1996;208:31-61. Review. No abstract available.

PMID:
8575212
6.

Melanoma cell autonomous growth: the Rb/E2F pathway.

Halaban R.

Cancer Metastasis Rev. 1999;18(3):333-43. Review.

PMID:
10721488
7.

The cell cycle kinases.

Pines J.

Semin Cancer Biol. 1994 Aug;5(4):305-13. Review.

PMID:
7803767
8.

Perspectives for cancer therapies with cdk2 inhibitors.

Wadler S.

Drug Resist Updat. 2001 Dec;4(6):347-67. Review.

PMID:
12030783
9.

Control of DNA replication by protein phosphorylation.

Boulikas T.

Anticancer Res. 1994 Nov-Dec;14(6B):2465-72. Review.

PMID:
7872668
10.

[Cyclin D, CDK4 and p16 expression in colorectal cancer].

Ikeda K, Monden T, Tsujie M, Izawa H, Yamamoto H, Ohnishi T, Ohue M, Sekimoto M, Tomita N, Monden M.

Nihon Rinsho. 1996 Apr;54(4):1054-9. Review. Japanese.

PMID:
8920673
11.

Structuring cell-cycle biology.

Levine K, Cross FR.

Structure. 1995 Nov 15;3(11):1131-4. Review.

12.

Driving the cell cycle to cancer.

Malumbres M, Hunt SL, Sotillo R, Martín J, Odajima J, Martín A, Dubus P, Ortega S, Barbacid M.

Adv Exp Med Biol. 2003;532:1-11. Review.

PMID:
12908544
13.

Cyclin-dependent kinases at the G1-S transition of the mammalian cell cycle.

Hengstschläger M, Braun K, Soucek T, Miloloza A, Hengstschläger-Ottnad E.

Mutat Res. 1999 Jan;436(1):1-9. Review.

PMID:
9878675
14.

[Cdc2 activation by phosphorylation].

Yamashita K.

Seikagaku. 1996 May;68(5):367-71. Review. Japanese. No abstract available.

PMID:
8727661
15.

Recent developments in cyclin-dependent kinase biochemical and structural studies.

Echalier A, Endicott JA, Noble ME.

Biochim Biophys Acta. 2010 Mar;1804(3):511-9. doi: 10.1016/j.bbapap.2009.10.002. Epub 2009 Oct 12. Review.

PMID:
19822225
16.

Mammalian cell-cycle regulation: several Cdks, numerous cyclins and diverse compensatory mechanisms.

Satyanarayana A, Kaldis P.

Oncogene. 2009 Aug 20;28(33):2925-39. doi: 10.1038/onc.2009.170. Epub 2009 Jun 29. Review.

PMID:
19561645
17.

Neuronal cdc2-like kinase.

Lew J, Wang JH.

Trends Biochem Sci. 1995 Jan;20(1):33-7. Review.

PMID:
7878742
18.

The regulation of protein phosphorylation.

Johnson LN.

Biochem Soc Trans. 2009 Aug;37(Pt 4):627-41. doi: 10.1042/BST0370627. Review.

PMID:
19614568
19.

Structural dissection of cyclin dependent kinases regulation and protein recognition properties.

Lolli G.

Cell Cycle. 2010 Apr 15;9(8):1551-61. Epub 2010 Apr 15. Review.

PMID:
20372077
20.

Metabolic adaptation to cancer growth: from the cell to the organism.

Escoté X, Fajas L.

Cancer Lett. 2015 Jan 28;356(2 Pt A):171-5. doi: 10.1016/j.canlet.2014.03.034. Epub 2014 Apr 4. Review.

PMID:
24709629
Items per page

Supplemental Content

Write to the Help Desk